Small-Cell Lung Cancer Treatment of Newly Diagnosed Patients with Poor Performance Status

Small-cell lung cancer (SCLC) is highly sensitive to platinum-based chemotherapy. However, its indication in patients with a poor performance status (PS) at initial diagnosis is controversial. We retrospectively reviewed all clinical courses of pathologically diagnosed SCLC patients with poor PS, Ea...

Descripción completa

Detalles Bibliográficos
Autores principales: Aida, Yuka, Nakazawa, Kensuke, Shiozawa, Toshihiro, Ogawa, Ryoko, Kiwamoto, Takumi, Morishima, Yuko, Sakamoto, Toru, Sekine, Ikuo, Hizawa, Nobuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738152/
https://www.ncbi.nlm.nih.gov/pubmed/31543777
http://dx.doi.org/10.1159/000501548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738152/
https://www.ncbi.nlm.nih.gov/pubmed/31543777
http://dx.doi.org/10.1159/000501548

Ejemplares similares